Akari Therapeutics, Plc (AKTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 243,222.4 |
| Enterprise Value | -4.21M |
| P/E Ratio | -0.01 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.02 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.48 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.83 |
| Return On Equity | -1.23 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -17.35M |
| Net Income | -17.3M |
| Diluted EPS | -20,800 |
Balance Sheet
| Total Cash | 2.77M |
| Total Cash/Share | 131.56 |
| Total Debt | 732,000 |
| Total Debt/Equity | 0.05 |
| Current Ratio | 0.27 |
| Book Value Per Share | 683.46 |
Price History
| 52-Week Change | -68.45 |
| 52-Week High | 49.6 |
| 52-Week Low | 3.02 |
| Moving Average 50 Days | 10.6 |
| Moving Average 200 Days | 14.6 |
Statistics
| Average Volume | 801,609 |
| Shares Outstanding | 1.14M |
| % Held by Institutions | 0.2 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | March 31, 2026 |
AD
